A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 495.26
C 32.87
GOOG 606.44
BAC 8.04
RIMM 15.57

Recently Added

CPIC 1.20
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.75

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.20
NBTH 12.50
AVEW 0.00
9.54 -0.27 (-2.77%) SCR

Click Here to Receive Instant E-mail and RSS Alerts


Trade SCR now with

Stock Details

Last Trade:9.54 Change:-0.27 (-2.77%) Prev Close:9.81 Open: 9.75 Days Range:9.41 – 9.75 52 Week Range: 7.12 - 13.72 Volume:5240 P/E: N/A
EPS:0.00





Recent Blog Posts

Blog Posts on 01/30/12 at 4:49am
Hedge Funds Love These 12 Chinese Stocks
Blog Posts on 01/26/12 at 4:31am
Hedge Funds Are Buying Up These 20 Healthcare Stocks
Blog Posts on 01/09/12 at 4:02am
Injured Chinese IPOs To Offer Value Opportunities
Blog Posts on 01/09/12 at 4:02am
Injured Chinese IPO's To Offer Value Opportunities
Blog Posts on 01/05/12 at 8:18am
Hedge Funds Are Buying These 20 BRIC Stocks
Blog Posts on 12/30/11 at 9:36am
10 Chinese Stocks For Profits In 2012, Part II
Blog Posts on 12/18/11 at 8:12am
China Biotech Week In Review: Simcere, BMS Add Cardiovascular Drug To Partnership
Blog Posts on 11/14/11 at 12:52pm
China Biotech Week In Review: WuXi PharmaTech Forms Venture Fund
Blog Posts on 10/23/11 at 9:33am
China Biotech Week In Review: SFDA Releases 2010 Approval Data
Blog Posts on 09/15/11 at 8:20am
Evolving Portfolio (Number 4): U.S. Rules OK
Blog Posts on 08/23/11 at 8:11am
Why Merck May Stagnate In 2012
Blog Posts on 05/24/11 at 1:36pm
China Biotech Q1 Earnings Review: Healthy Revenue Increases, Smaller Profit Growth
Blog Posts on 05/15/11 at 8:39am
China Biotech Week in Review: Deals and Transactions, SFDA Approvals
Blog Posts on 04/21/11 at 4:45pm
Top Pharma Stocks That Hedge Funds Love
Blog Posts on 03/10/11 at 11:18am
Revenues Rise at Simcere Pharmaceutical
Blog Posts on 01/20/11 at 5:09pm
15 Small Cap Stocks With Great Management Teams
Blog Posts on 11/07/10 at 5:40am
China Biotech Week in Review: Major Cross-Border Initiatives
Blog Posts on 11/04/10 at 9:32am
BMS Partners With Simcere as Low-Cost Strategy to Advance Prospective Cancer Drug
Blog Posts on 09/21/10 at 1:37pm
Think Healthcare Ahead of China's 12th Five-Year Plan
Blog Posts on 09/17/10 at 5:55am
Thoughts on Chinese Pharma Stocks
Blog Posts on 08/15/10 at 4:08am
China Biotech Week in Review: More Support for Biopharma
Blog Posts on 08/13/10 at 2:16am
Simcere Wins Approval for Anti-Nausea Drug, Reports Disappointing Q2
Blog Posts on 06/08/10 at 5:25am
Simcere Pharma Ups Stake in Boda Pharma to 90%
Blog Posts on 05/23/10 at 5:52am
China Biotech Week in Review: Deals Abound
Blog Posts on 05/17/10 at 10:03am
Simcere Wants to Sell OTC Division, Add Prescription Drug Partnerships
Blog Posts on 04/26/10 at 6:07am
China Biotech Week in Review: Focus on Innovation
Blog Posts on 04/22/10 at 12:38pm
Simcere Pharma Moves Closer to International Sales With Approval for Diarrhea Drug
Blog Posts on 04/11/10 at 4:18am
China Biotech Week in Review: ICON, Tigermed Form China CRO Partnership
Blog Posts on 04/05/10 at 1:52pm
Operations of Simcere's Latest Acquisition Remain Shut Down
Blog Posts on 03/28/10 at 4:44am
China Biotech Week in Review: Cross-Border Collaboration